These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16055674)

  • 41. Fibroblast-dependent differentiation of human microvascular endothelial cells into capillary-like 3-dimensional networks.
    Velazquez OC; Snyder R; Liu ZJ; Fairman RM; Herlyn M
    FASEB J; 2002 Aug; 16(10):1316-8. PubMed ID: 12060671
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The receptor tyrosine kinase inhibitor SU11248 impedes endothelial cell migration, tubule formation, and blood vessel formation in vivo, but has little effect on existing tumor vessels.
    Osusky KL; Hallahan DE; Fu A; Ye F; Shyr Y; Geng L
    Angiogenesis; 2004; 7(3):225-33. PubMed ID: 15609077
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Construction of a three-dimensional human angiogenesis model in vitro for antiangiogenic drug selection].
    Li B
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1167-70. PubMed ID: 15485791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ruboxistaurin, a PKCbeta inhibitor, inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt.
    Nakamura S; Chikaraishi Y; Tsuruma K; Shimazawa M; Hara H
    Exp Eye Res; 2010 Jan; 90(1):137-45. PubMed ID: 19825373
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide.
    Ferrari N; Pfeffer U; Dell'Eva R; Ambrosini C; Noonan DM; Albini A
    Clin Cancer Res; 2005 Jun; 11(12):4610-9. PubMed ID: 15958647
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668.
    Zhang H; Issekutz AC
    Am J Pathol; 2002 Jun; 160(6):2219-30. PubMed ID: 12057924
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiangiogenic potential of camptothecin and topotecan.
    Clements MK; Jones CB; Cumming M; Daoud SS
    Cancer Chemother Pharmacol; 1999; 44(5):411-6. PubMed ID: 10501915
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1.
    Schmid G; Guba M; Ischenko I; Papyan A; Joka M; Schrepfer S; Bruns CJ; Jauch KW; Heeschen C; Graeb C
    J Cell Biochem; 2007 May; 101(1):259-70. PubMed ID: 17203465
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human adipose-derived stem cells enhance the angiogenic potential of endothelial progenitor cells, but not of human umbilical vein endothelial cells.
    Strassburg S; Nienhueser H; Stark GB; Finkenzeller G; Torio-Padron N
    Tissue Eng Part A; 2013 Jan; 19(1-2):166-74. PubMed ID: 22871242
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels.
    Goto F; Goto K; Weindel K; Folkman J
    Lab Invest; 1993 Nov; 69(5):508-17. PubMed ID: 8246443
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outer membrane vesicles from Porphyromonas gingivalis affect the growth and function of cultured human gingival fibroblasts and umbilical vein endothelial cells.
    Bartruff JB; Yukna RA; Layman DL
    J Periodontol; 2005 Jun; 76(6):972-9. PubMed ID: 15948693
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The use of adipose mesenchymal stem cells and human umbilical vascular endothelial cells on a fibrin matrix for endothelialized skin substitute.
    Sánchez-Muñoz I; Granados R; Holguín Holgado P; García-Vela JA; Casares C; Casares M
    Tissue Eng Part A; 2015 Jan; 21(1-2):214-23. PubMed ID: 25007712
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adipokine resistin promotes in vitro angiogenesis of human endothelial cells.
    Mu H; Ohashi R; Yan S; Chai H; Yang H; Lin P; Yao Q; Chen C
    Cardiovasc Res; 2006 Apr; 70(1):146-57. PubMed ID: 16515776
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.
    Qian DZ; Kato Y; Shabbeer S; Wei Y; Verheul HM; Salumbides B; Sanni T; Atadja P; Pili R
    Clin Cancer Res; 2006 Jan; 12(2):634-42. PubMed ID: 16428510
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-angiogenic effects of a nutrient mixture on human umbilical vein endothelial cells.
    Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
    Oncol Rep; 2005 Dec; 14(6):1399-404. PubMed ID: 16273231
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Albendazole inhibits endothelial cell migration, tube formation, vasopermeability, VEGF receptor-2 expression and suppresses retinal neovascularization in ROP model of angiogenesis.
    Pourgholami MH; Khachigian LM; Fahmy RG; Badar S; Wang L; Chu SW; Morris DL
    Biochem Biophys Res Commun; 2010 Jul; 397(4):729-34. PubMed ID: 20537982
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-angiogenic actions of pyrrolidine dithiocarbamate, a nuclear factor kappa B inhibitor.
    Morais C; Gobe G; Johnson DW; Healy H
    Angiogenesis; 2009; 12(4):365-79. PubMed ID: 19882112
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-angiogenic effect of Biophytum sensitivum is exerted through its cytokine modulation activity and inhibitory activity against VEGF mRNA expression, endothelial cell migration and capillary tube formation.
    Guruvayoorappan C; Kuttan G
    J Exp Ther Oncol; 2007; 6(3):241-50. PubMed ID: 17552364
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel, microcarrier-based in vitro assay for rapid and reliable quantification of three-dimensional cell migration and angiogenesis.
    Nehls V; Drenckhahn D
    Microvasc Res; 1995 Nov; 50(3):311-22. PubMed ID: 8583947
    [TBL] [Abstract][Full Text] [Related]  

  • 60. AMG 706, an oral, multikinase inhibitor that selectively targets vascular endothelial growth factor, platelet-derived growth factor, and kit receptors, potently inhibits angiogenesis and induces regression in tumor xenografts.
    Polverino A; Coxon A; Starnes C; Diaz Z; DeMelfi T; Wang L; Bready J; Estrada J; Cattley R; Kaufman S; Chen D; Gan Y; Kumar G; Meyer J; Neervannan S; Alva G; Talvenheimo J; Montestruque S; Tasker A; Patel V; Radinsky R; Kendall R
    Cancer Res; 2006 Sep; 66(17):8715-21. PubMed ID: 16951187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.